Johnny N. Mahlangu

Johannesburg, GT, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 198 publications

Advances in treatments for hemophilia A/B with inhibitors: current treatment gaps and promising therapies.

Advances in treatments for hemophilia A/B with inhibitors: current treatment gaps and promising therapies.

Journal: Expert review of hematology

Published: July 08, 2026

Knowledge on the Haemophilia Care Among Healthcare Providers in Tanzania: A Multicenter Cross-Sectional Study.

Knowledge on the Haemophilia Care Among Healthcare Providers in Tanzania: A Multicenter Cross-Sectional Study.

Journal: Journal of blood medicine

Published: June 07, 2026

Prevalence of Prosthetic Joint Infections in Patients With Haemophilic Arthropathy Treated at a Tertiary Hospital: A Retrospective Case-Control Study.

Prevalence of Prosthetic Joint Infections in Patients With Haemophilic Arthropathy Treated at a Tertiary Hospital: A Retrospective Case-Control Study.

Journal: Cureus

Published: June 01, 2026

Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

Journal: The New England journal of medicine

Published: April 29, 2026

A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab.

A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimab.

Journal: Therapeutic advances in hematology

Published: March 11, 2026

Is marstacimab the next step in personalized and effective haemophilia management?

Is marstacimab the next step in personalized and effective haemophilia management?

Journal: Expert review of clinical pharmacology

Published: February 27, 2026

Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study.

Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study.

Journal: Therapeutic advances in hematology

Published: January 28, 2026

Management of breakthrough bleeds and surgical procedures in participants with hemophilia A or B without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS study.

Management of breakthrough bleeds and surgical procedures in participants with hemophilia A or B without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 09, 2025

Enhancing the Evidence for Care in Underserved Bleeding Disorders Communities.

Enhancing the Evidence for Care in Underserved Bleeding Disorders Communities.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 24, 2025

A revised classification of FVIII concentrates: rationale and novel metrics.

A revised classification of FVIII concentrates: rationale and novel metrics.

Journal: Blood advances

Published: November 13, 2025

A Revised Classification of FVIII Concentrates: Rationale and Novel Metrics.

A Revised Classification of FVIII Concentrates: Rationale and Novel Metrics.

Journal: Blood advances

Published: November 13, 2025

Futuristic global cell and gene therapy regulations based on a review of today's leading frameworks.

Futuristic global cell and gene therapy regulations based on a review of today's leading frameworks.

Journal: Cytotherapy

Published: October 16, 2025

Showing 1-12 of 198

Last Updated: 09/26/2026